RE:RE:Curious as to how the trial changes affect posted results !Yes, it would be great to start seeing some 2 year data. As of the
29 Aug 23 MD&A, 39 patients had reached the
15 month point. By the end of this month
those 39 patients will have reached 24 months.
As of
29 Aug 23,
13 patients out of 39 (or 33%) were CR at 15 months. If the
24 month data of all 39 were made available it would be very instructive
how many of those 13 patients are still CR. Donein25 wrote: I think there will have to be new data sets because there will be new subsets of patients. Also, I think (due to BTD/AA requirements) that we might start to see 2 year data soon. I personally would be encouraged to see 2 year data come out...as it would say to me that we are complying with current FDA reporting requirements.